TIM
KROS icon

Tortoise Investment Management’s Keros Therapeutics KROS Stock Holding History

Tortoise Investment Management’s Portfolio KROS Stock Details KROS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-312
Closed -$9.95K – 808
2023
Q3 		$9.95K Hold
312
– – ﹤0.01% 558
2023
Q2 		$12.5K Hold
312
– – ﹤0.01% 525
2023
Q1 		$13.3K Hold
312
– – ﹤0.01% 512
2022
Q4 		$15K Hold
312
– – ﹤0.01% 496
2022
Q3 		$12K Hold
312
– – ﹤0.01% 502
2022
Q2 		$9K Hold
312
– – ﹤0.01% 530
2022
Q1 		$17K Hold
312
– – ﹤0.01% 444
2021
Q4 		$18K Hold
312
– – ﹤0.01% 418
2021
Q3 		$12K Hold
312
– – ﹤0.01% 448
2021
Q2 		$13K Buy
312
+219
+235% +$11.9K ﹤0.01% 433
2021
Q1 		$6K Buy
+93
New +$5.89K ﹤0.01% 483

Other funds holding KROS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $22.1B AUM 51.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return